Market Research Logo

US Market Report for Dental Growth Factor 2017 - MedCore

US Market Report for Dental Growth Factor 2017 - MedCore

General Report Contents

  • Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
  • Market Drivers & Limiters for each chapter segment
  • Competitive Analysis for each chapter segment
  • Section on recent mergers & acquisitions
Most of the new products in this area are derived from advances made in the orthopedic field. However, adapting an orthopedic product for dental applications is not straightforward – a separate approval must be obtained from the U.S. Food and Drug Administration (FDA) for dental use. This has created a significant delay between when products are introduced to the orthopedic market and when they enter the dental market.

Dental growth factor products currently offered to the U.S. market in 2016 were GEM 21S®, INFUSE®, Osteocel® and Emdogain™. Over the forecast period, a number of additional growth factor combinations are expected to enter the tissue engineering product market. In 2005, the FDA approved the release of BioMimetic’s GEM 21S®, the first growth factor matrix approved for dental use. The product has since gained traction and received the CE mark approval to enter the European market in 2012.

In late 2006, Medtronic’s INFUSE®, a growth factor containing bone graft product, was also approved for dental use. Tissue engineering products are often employed in combination with bone graft substitutes. Certain products cater to a specific need; for that reason, the various growth factors in the market are not viewed as complete substitutes or directly in competition with one another.

Osteoinductivity refers to the ability of a graft to induce non-differentiated stem cells, or osteoprogenitor cells, to differentiate into osteoblasts, resulting in bone regeneration. However, only a few bone graft substitute materials have the capacity for osteoconductivity. Growth factors and other tissue engineering products enhance osteoconductivity, and are used to increase the rate and volume of bone regeneration.

Dental growth factor and tissue engineering products is a broad category that encompasses products used for facilitating and enhancing bone regeneration. This includes growth factors and enamel matrix protein solutions. Platelet rich plasma (PRP) is also used for these purposes, but will not be considered within this report.


EXECUTIVE SUMMARY
U.S. DENTAL BONE GRAFT SUBSTITUTES AND OTHER BIOMATERIALS MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURES COVERED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Dental Anatomy: Oral Cavity and Intraoral landmarks
2.2 DISEASE PATHOLOGY AND DISORDERS
2.2.1 General Diagnostics
2.2.2 Indication for Dental Implant
2.2.2.1 Periodontal Disease
2.2.2.2 Dental Implant Procedures
2.3 PATIENT DEMOGRAPHICS
2.3.1 General Dental Statistics
2.3.2 Tooth Loss Statistics
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Dental Growth Factor Products
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 Dental Bone Graft Substitutes
3.3 CLINICAL TRIALS
3.3.1 Dental Bone Graft Substitutes
DENTAL GROWTH FACTOR MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Emdogain® Market
4.3.2 GEM 21S® Market
4.3.3 INFUSE® Market
4.3.4 Osteocel® Market
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 EMERGING COMPETITORS AND TECHNOLOGIES
4.6.1 Cowell BMP®
4.6.2 OssGen-X15®
4.6.3 PEP7
4.6.4 Platelet Rich Plasma (PRP)
4.6.5 rhGDF-5
4.6.6 Stem Cell Based Therapies
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Dental Bone Graft Substitutes and Other Biomaterials Market by Segment, U.S., 2013 – 2023
Chart 1 2: Dental Bone Graft Substitutes and Other Biomaterials Market Overview, U.S., 2016 & 2023
Chart 4 1: Dental Growth Factor Market by Segment, U.S., 2013 – 2023
Chart 4 2: Dental Growth Factor Market Breakdown, U.S., 2016
Chart 4 3: Dental Growth Factor Market Breakdown, U.S., 2023
Chart 4 4: Emdogain® Market, U.S., 2013 – 2023
Chart 4 5: GEM 21S® Market, U.S., 2013 – 2023
Chart 4 6: INFUSE® Market, U.S., 2013 – 2023
Chart 4 7: Osteocel® Market, U.S., 2013 – 2023
Chart 4 8: Leading Competitors, Dental Growth Factor Market, U.S., 2016
List of Figures
Figure 1 1: Dental Bone Graft Substitutes and Other Biomaterials Market Share Ranking by Segment, U.S., 2016
Figure 1 2: Companies Researched in this Report, U.S., 2016
Figure 1 3: Factors Impacting the Dental Bone Graft Substitutes and Other Biomaterials Market by Segment, U.S.
Figure 1 4: Recent Events in the Dental Bone Graft Substitutes and Other Biomaterials Market, U.S., 2013 – 2016
Figure 1 5: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016
Figure 1 6: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016 (1 of 2)
Figure 1 7: Dental Bone Graft Substitutes and Other Biomaterials Markets Covered, U.S., 2016 (2 of 2)
Figure 1 8: Key Report Updates
Figure 1 9: Version History
Figure 3 1: Dental Growth Products by Company
Figure 3 2: Class 3 Device Recall ZCORE Syringe
Figure 3 3: Class 2 Device Recall Collagen Matrix Inc.
Figure 3 4: Class 2 Device Recall Endobon Xenograft Granules, Biomet France SARL
Figure 3 5: Class 3 Device Recall ENDOBON XENOGRAFT GRANULES 0.5 ML
Figure 3 6: Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft (Mucograft)
Figure 3 7: Prospective, Comparative Assessment of Alveolar Bone Augmentation Using GUIDOR® Membrane
Figure 3 8: Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
Figure 3 9: Guided Bone Regeneration Using Synthetic Membrane
Figure 3 10: Histological Comparison of Ridge Preservation Using Mineralized FDBA Alone Versus a Combined Mineralized-Demineralized Freeze Dried Bone Allograft
Figure 3 11: A Randomized Control Trial Testing Connective Tissue Grafts vs. Allograft on Dental Implants
Figure 4 1: Dental Growth Factor Market by Segment, U.S., 2013 – 2023 (US$M)
Figure 4 2: Emdogain® Market, U.S., 2013 – 2023
Figure 4 3: GEM 21S® Market, U.S., 2013 – 2023
Figure 4 4: INFUSE® Market, U.S., 2013 – 2023
Figure 4 5: Osteocel® Market, U.S., 2013 – 2023
Figure 4 6: Drivers and Limiters, Dental Growth Factor Market, U.S., 2016
Figure 4 7: Leading Competitors, Dental Growth Factor Market, U.S., 2016
Figure 6 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report